PortfoliosLab logoPortfoliosLab logo
BNTX vs. MOH
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BNTX vs. MOH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BioNTech SE (BNTX) and Molina Healthcare, Inc. (MOH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BNTX achieves a -7.09% return, which is significantly lower than MOH's 6.50% return.


BNTX

1D
-0.77%
1M
-10.97%
YTD
-7.09%
6M
-8.56%
1Y
-23.51%
3Y*
-6.48%
5Y*
-17.26%
10Y*

MOH

1D
2.76%
1M
-5.48%
YTD
6.50%
6M
23.97%
1Y
-37.05%
3Y*
-13.66%
5Y*
-5.79%
10Y*
13.86%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BNTX vs. MOH - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
BNTX
BioNTech SE
-7.09%-16.45%7.97%-29.74%-40.40%216.24%140.61%137.92%
MOH
Molina Healthcare, Inc.
6.50%-40.37%-19.45%9.41%3.82%49.56%56.74%20.03%

Correlation

The correlation between BNTX and MOH is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.09

Correlation (5Y)
Calculated over the trailing 5-year period

0.11

Correlation (All Time)
Calculated using the full available price history since Oct 11, 2019

0.11

The correlation between BNTX and MOH shifts across timeframes, from 0.09 (3 years) to 0.19 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

BNTX:

$22.37B

MOH:

$9.43B

EPS

BNTX:

-$5.14

MOH:

$3.59

PS Ratio

BNTX:

7.73

MOH:

0.21

PB Ratio

BNTX:

1.20

MOH:

2.31

Total Revenue (TTM)

BNTX:

$2.80B

MOH:

$45.08B

Gross Profit (TTM)

BNTX:

$2.05B

MOH:

$2.80B

EBITDA (TTM)

BNTX:

-$815.04M

MOH:

$617.00M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BNTX vs. MOH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BNTX
BNTX Risk / Return Rank: 1313
Overall Rank
BNTX Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
BNTX Sortino Ratio Rank: 1818
Sortino Ratio Rank
BNTX Omega Ratio Rank: 1616
Omega Ratio Rank
BNTX Calmar Ratio Rank: 1111
Calmar Ratio Rank
BNTX Martin Ratio Rank: 33
Martin Ratio Rank

MOH
MOH Risk / Return Rank: 1818
Overall Rank
MOH Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
MOH Sortino Ratio Rank: 1818
Sortino Ratio Rank
MOH Omega Ratio Rank: 1616
Omega Ratio Rank
MOH Calmar Ratio Rank: 1818
Calmar Ratio Rank
MOH Martin Ratio Rank: 2424
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BNTX vs. MOH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BioNTech SE (BNTX) and Molina Healthcare, Inc. (MOH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BNTXMOHDifference
Sharpe ratioReturn per unit of total volatility

+0.05

Sortino ratioReturn per unit of downside risk

-0.04

Omega ratioGain probability vs. loss probability

0.92

0.91

+0.01

Calmar ratioReturn relative to maximum drawdown

-0.79

-0.62

-0.17

Martin ratioReturn relative to average drawdown

-1.68

-0.85

-0.82

BNTX vs. MOH - Sharpe Ratio Comparison

The current BNTX Sharpe Ratio is -0.58, which is comparable to the MOH Sharpe Ratio of -0.63. The chart below compares the historical Sharpe Ratios of BNTX and MOH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


BNTXMOHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.58

-0.63

+0.05

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.31

-0.15

-0.17

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.34

Sharpe Ratio (All Time)

Calculated using the full available price history

0.42

0.29

+0.14

Drawdowns

BNTX vs. MOH - Drawdown Comparison

The maximum BNTX drawdown since its inception was -82.08%, which is greater than MOH's maximum drawdown of -70.76%. Use the drawdown chart below to compare losses from any high point for BNTX and MOH.


Loading charts...

Drawdown Indicators


BNTXMOHDifference

Max Drawdown

Largest peak-to-trough decline

-82.08%

-70.76%

-11.32%

Max Drawdown (1Y)

Largest decline over 1 year

-29.71%

-59.96%

+30.25%

Max Drawdown (3Y)

Largest decline over 3 years

-37.35%

-70.76%

+33.41%

Max Drawdown (5Y)

Largest decline over 5 years

-82.08%

-70.76%

-11.32%

Max Drawdown (10Y)

Largest decline over 10 years

-70.76%

Current Drawdown

Current decline from peak

-79.77%

-55.95%

-23.82%

Average Drawdown

Average peak-to-trough decline

-56.12%

-24.57%

-31.55%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.30%

43.55%

-29.25%

Volatility

BNTX vs. MOH - Volatility Comparison

The current volatility for BioNTech SE (BNTX) is 8.96%, while Molina Healthcare, Inc. (MOH) has a volatility of 11.13%. This indicates that BNTX experiences smaller price fluctuations and is considered to be less risky than MOH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BNTXMOHDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.96%

11.13%

-2.17%

Volatility (6M)

Calculated over the trailing 6-month period

33.77%

43.33%

-9.56%

Volatility (1Y)

Calculated over the trailing 1-year period

41.08%

59.41%

-18.33%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

55.62%

39.82%

+15.80%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

76.31%

40.72%

+35.59%

Dividends

BNTX vs. MOH - Dividend Comparison

Neither BNTX nor MOH has paid dividends to shareholders.


PositionTTM2025202420232022
BNTX
BioNTech SE
0.00%0.00%0.00%0.00%2.43%
MOH
Molina Healthcare, Inc.
0.00%0.00%0.00%0.00%0.00%

Financials

BNTX vs. MOH - Financials Comparison

This section allows you to compare key financial metrics between BioNTech SE and Molina Healthcare, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00B20222023202420252026
120.04M
10.80B
(BNTX) Total Revenue
(MOH) Total Revenue
Values in USD except per share items

Frequently Asked Questions


BNTX and MOH have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MOH has higher volatility (11.13%) compared to BNTX (8.96%). In terms of maximum drawdown, BNTX dropped -82.08% vs MOH's -70.76%.

BNTX currently has the higher Sharpe Ratio (-0.58 vs -0.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BNTX and MOH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer